

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.91072456 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.69313789 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.69313789 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.34224487 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.34224487 |
| 6 | * aromatic amino acid family catabolic process (GO:0009074) | 6.79260628 |
| 7 | drug metabolic process (GO:0017144) | 6.41110532 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.20163850 |
| 9 | bile acid biosynthetic process (GO:0006699) | 6.15707649 |
| 10 | oxidative demethylation (GO:0070989) | 6.07634509 |
| 11 | * tryptophan catabolic process (GO:0006569) | 5.94991512 |
| 12 | * indole-containing compound catabolic process (GO:0042436) | 5.94991512 |
| 13 | * indolalkylamine catabolic process (GO:0046218) | 5.94991512 |
| 14 | urea cycle (GO:0000050) | 5.85524719 |
| 15 | urea metabolic process (GO:0019627) | 5.85524719 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.80615456 |
| 17 | * kynurenine metabolic process (GO:0070189) | 5.73105645 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.63843603 |
| 19 | * tryptophan metabolic process (GO:0006568) | 5.60417734 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.55955859 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.53502283 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.48310684 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.45540298 |
| 24 | cysteine metabolic process (GO:0006534) | 5.39187711 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.38492487 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.38256743 |
| 27 | protein carboxylation (GO:0018214) | 5.36898596 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.36898596 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.36487555 |
| 30 | ethanol metabolic process (GO:0006067) | 5.22633452 |
| 31 | regulation of plasminogen activation (GO:0010755) | 5.22034132 |
| 32 | bile acid metabolic process (GO:0008206) | 5.20936289 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.15018036 |
| 34 | regulation of complement activation (GO:0030449) | 5.14637121 |
| 35 | phenylpropanoid metabolic process (GO:0009698) | 5.11804841 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.03133620 |
| 37 | S-adenosylmethionine metabolic process (GO:0046500) | 5.02434515 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.94297995 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.88146264 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.87909712 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.87391682 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.87391682 |
| 43 | * aromatic amino acid family metabolic process (GO:0009072) | 4.87038461 |
| 44 | acute-phase response (GO:0006953) | 4.85480703 |
| 45 | regulation of humoral immune response (GO:0002920) | 4.78803232 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.75727108 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.73107504 |
| 48 | lysine metabolic process (GO:0006553) | 4.69646831 |
| 49 | lysine catabolic process (GO:0006554) | 4.69646831 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.69063504 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.69063504 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.69063504 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.66788094 |
| 54 | * alpha-amino acid catabolic process (GO:1901606) | 4.65861156 |
| 55 | negative regulation of protein activation cascade (GO:2000258) | 4.63785134 |
| 56 | opsonization (GO:0008228) | 4.63308389 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.58448847 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.58448847 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.52288627 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.52027803 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.52027803 |
| 62 | phospholipid efflux (GO:0033700) | 4.48343576 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.46974226 |
| 64 | glycine metabolic process (GO:0006544) | 4.45772250 |
| 65 | negative regulation of coagulation (GO:0050819) | 4.45045448 |
| 66 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.44576556 |
| 67 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.44576556 |
| 68 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.43119176 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.40648807 |
| 70 | negative regulation of wound healing (GO:0061045) | 4.39272860 |
| 71 | cellular glucuronidation (GO:0052695) | 4.38806648 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 4.37610843 |
| 73 | plasma lipoprotein particle clearance (GO:0034381) | 4.28611380 |
| 74 | * cellular amino acid catabolic process (GO:0009063) | 4.28304132 |
| 75 | glutamate metabolic process (GO:0006536) | 4.27651998 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.23506919 |
| 77 | flavonoid metabolic process (GO:0009812) | 4.17692644 |
| 78 | cholesterol efflux (GO:0033344) | 4.16946719 |
| 79 | ethanol oxidation (GO:0006069) | 4.15534641 |
| 80 | alkaloid metabolic process (GO:0009820) | 4.14752751 |
| 81 | * indolalkylamine metabolic process (GO:0006586) | 4.13119367 |
| 82 | positive regulation of hemostasis (GO:1900048) | 4.09282780 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 4.09282780 |
| 84 | arginine metabolic process (GO:0006525) | 4.08944065 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 4.08747733 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08487185 |
| 87 | hormone catabolic process (GO:0042447) | 4.07584703 |
| 88 | intestinal cholesterol absorption (GO:0030299) | 4.06123552 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 4.03431468 |
| 90 | aldehyde catabolic process (GO:0046185) | 4.01328866 |
| 91 | * cellular biogenic amine catabolic process (GO:0042402) | 4.00040063 |
| 92 | * amine catabolic process (GO:0009310) | 4.00040063 |
| 93 | fibrinolysis (GO:0042730) | 3.99290167 |
| 94 | drug catabolic process (GO:0042737) | 3.96912217 |
| 95 | response to mercury ion (GO:0046689) | 3.96102817 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 3.94367445 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 3.92850727 |
| 98 | * benzene-containing compound metabolic process (GO:0042537) | 3.92170632 |
| 99 | cytolysis (GO:0019835) | 3.90144476 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.89433146 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.89433146 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.87932647 |
| 103 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.86656432 |
| 104 | cofactor catabolic process (GO:0051187) | 3.86078177 |
| 105 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83812210 |
| 106 | complement activation (GO:0006956) | 3.83185442 |
| 107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80356800 |
| 108 | positive regulation of coagulation (GO:0050820) | 3.78893041 |
| 109 | ketone body metabolic process (GO:1902224) | 3.78759374 |
| 110 | protein activation cascade (GO:0072376) | 3.77744722 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76806304 |
| 112 | polyketide metabolic process (GO:0030638) | 3.76794011 |
| 113 | doxorubicin metabolic process (GO:0044598) | 3.76794011 |
| 114 | daunorubicin metabolic process (GO:0044597) | 3.76794011 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 3.74811849 |
| 116 | * organic acid catabolic process (GO:0016054) | 3.74777543 |
| 117 | * carboxylic acid catabolic process (GO:0046395) | 3.74777543 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73390365 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73390365 |
| 120 | phospholipid homeostasis (GO:0055091) | 3.73199389 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.72109213 |
| 122 | cholesterol homeostasis (GO:0042632) | 3.71861428 |
| 123 | epoxygenase P450 pathway (GO:0019373) | 3.69376676 |
| 124 | xenobiotic metabolic process (GO:0006805) | 3.68694997 |
| 125 | negative regulation of complement activation (GO:0045916) | 3.67333469 |
| 126 | sterol homeostasis (GO:0055092) | 3.65682080 |
| 127 | regulation of cholesterol homeostasis (GO:2000188) | 3.64514784 |
| 128 | short-chain fatty acid metabolic process (GO:0046459) | 3.64496016 |
| 129 | NAD biosynthetic process (GO:0009435) | 3.59257341 |
| 130 | exogenous drug catabolic process (GO:0042738) | 3.58774149 |
| 131 | acute inflammatory response (GO:0002526) | 3.57214019 |
| 132 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55584400 |
| 133 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55584400 |
| 134 | heme transport (GO:0015886) | 3.55286279 |
| 135 | sodium-independent organic anion transport (GO:0043252) | 3.53137721 |
| 136 | primary alcohol catabolic process (GO:0034310) | 3.49815049 |
| 137 | regulation of apoptotic cell clearance (GO:2000425) | 3.41600833 |
| 138 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.37878994 |
| 139 | regulation of acute inflammatory response (GO:0002673) | 3.35991601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38217308 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19581923 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.08072982 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51605789 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.35381196 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.10784894 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.74856645 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.10044830 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01585949 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09065071 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9887837 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96301448 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94756294 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60751532 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59881987 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54198424 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47219502 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46977445 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40429071 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23556628 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18976582 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18051011 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17283678 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01626313 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99869703 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99653042 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95634740 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94667959 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94371154 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91881597 |
| 31 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89244434 |
| 32 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.87254983 |
| 33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84559855 |
| 34 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84080704 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83763407 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82515948 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81078132 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79047969 |
| 39 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.78705750 |
| 40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78676407 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78665359 |
| 42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78353509 |
| 43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77301993 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77018153 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76389492 |
| 46 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75658766 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.73789852 |
| 48 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72733349 |
| 49 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72689391 |
| 50 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.72644160 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71622793 |
| 52 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71401336 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70945516 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.70813437 |
| 55 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70201732 |
| 56 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69445519 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68899139 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68899139 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68621301 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.68501465 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67524915 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66644670 |
| 63 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.66032350 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64989058 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.63841669 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62730978 |
| 67 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62291811 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.59800189 |
| 69 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59557233 |
| 70 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58672082 |
| 71 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.58451931 |
| 72 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.57990806 |
| 73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57364123 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57134879 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.57062450 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56994676 |
| 77 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.56733236 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.55746760 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.54960543 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54545724 |
| 81 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53490873 |
| 82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52792963 |
| 83 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52634501 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.52604064 |
| 85 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.52434524 |
| 86 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.52376450 |
| 87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51443156 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.51378552 |
| 89 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51177017 |
| 90 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50776734 |
| 91 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.50440662 |
| 92 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.50200657 |
| 93 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.50143885 |
| 94 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.49977253 |
| 95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49813413 |
| 96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49769086 |
| 97 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49272793 |
| 98 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49141959 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.48916947 |
| 100 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.48915279 |
| 101 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.48564250 |
| 102 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.48456243 |
| 103 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47799930 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47709053 |
| 105 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.47071057 |
| 106 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46483704 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.46397771 |
| 108 | NFYB_21822215_ChIP-Seq_K562_Human | 0.46366806 |
| 109 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46355379 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45233702 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44365033 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42644218 |
| 113 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42634589 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42380934 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42154797 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41939919 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41887578 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41863370 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40473964 |
| 120 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40164628 |
| 121 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39178165 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38628554 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38208430 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37665749 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37402216 |
| 126 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37336685 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37310849 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37295141 |
| 129 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37084184 |
| 130 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36509402 |
| 131 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36299080 |
| 132 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.35246199 |
| 133 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35108150 |
| 134 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35054822 |
| 135 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34975039 |
| 136 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34545825 |
| 137 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34297865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.35345172 |
| 2 | MP0005360_urolithiasis | 7.52777920 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.55539049 |
| 4 | MP0005365_abnormal_bile_salt | 6.25678536 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18426693 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.29851624 |
| 7 | MP0003252_abnormal_bile_duct | 4.01032719 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.54600342 |
| 9 | MP0009840_abnormal_foam_cell | 3.17669574 |
| 10 | MP0005083_abnormal_biliary_tract | 3.02567447 |
| 11 | MP0003195_calcinosis | 2.78343430 |
| 12 | MP0005332_abnormal_amino_acid | 2.76215767 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.60799805 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.21561549 |
| 15 | MP0000609_abnormal_liver_physiology | 2.15992981 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.09720438 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09276439 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01321206 |
| 19 | MP0003868_abnormal_feces_composition | 1.99086817 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83729997 |
| 21 | MP0001764_abnormal_homeostasis | 1.68931218 |
| 22 | MP0009697_abnormal_copulation | 1.61998384 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55691319 |
| 24 | MP0005451_abnormal_body_composition | 1.41476331 |
| 25 | MP0003011_delayed_dark_adaptation | 1.34426364 |
| 26 | MP0003186_abnormal_redox_activity | 1.25692059 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.21614502 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.21136700 |
| 29 | MP0000598_abnormal_liver_morphology | 1.17658557 |
| 30 | MP0005647_abnormal_sex_gland | 1.15833056 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.12910608 |
| 32 | MP0009764_decreased_sensitivity_to | 1.06445213 |
| 33 | MP0000604_amyloidosis | 1.02812575 |
| 34 | MP0009763_increased_sensitivity_to | 1.01534722 |
| 35 | MP0002254_reproductive_system_inflammat | 1.00944661 |
| 36 | MP0010368_abnormal_lymphatic_system | 0.94259314 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.89927039 |
| 38 | MP0008469_abnormal_protein_level | 0.88714015 |
| 39 | MP0005670_abnormal_white_adipose | 0.87108931 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.85799231 |
| 41 | MP0005408_hypopigmentation | 0.84810266 |
| 42 | MP0005023_abnormal_wound_healing | 0.82491889 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.80585150 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.79975512 |
| 45 | MP0001915_intracranial_hemorrhage | 0.79812238 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.78861392 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 0.78752161 |
| 48 | MP0002876_abnormal_thyroid_physiology | 0.76675965 |
| 49 | MP0002282_abnormal_trachea_morphology | 0.76011320 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.75984688 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 0.73407943 |
| 52 | MP0004130_abnormal_muscle_cell | 0.70907202 |
| 53 | MP0002971_abnormal_brown_adipose | 0.70718333 |
| 54 | MP0005334_abnormal_fat_pad | 0.68344562 |
| 55 | MP0003690_abnormal_glial_cell | 0.68151746 |
| 56 | MP0005535_abnormal_body_temperature | 0.68123128 |
| 57 | MP0009785_altered_susceptibility_to | 0.66982754 |
| 58 | MP0005266_abnormal_metabolism | 0.65928211 |
| 59 | MP0001661_extended_life_span | 0.64323871 |
| 60 | MP0009053_abnormal_anal_canal | 0.63364418 |
| 61 | MP0005187_abnormal_penis_morphology | 0.61688041 |
| 62 | MP0003329_amyloid_beta_deposits | 0.60988970 |
| 63 | MP0000639_abnormal_adrenal_gland | 0.59082637 |
| 64 | MP0003879_abnormal_hair_cell | 0.58023763 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 0.57834157 |
| 66 | MP0001756_abnormal_urination | 0.56141962 |
| 67 | MP0005448_abnormal_energy_balance | 0.52518531 |
| 68 | MP0005464_abnormal_platelet_physiology | 0.49518503 |
| 69 | MP0002928_abnormal_bile_duct | 0.48915788 |
| 70 | MP0004381_abnormal_hair_follicle | 0.48139359 |
| 71 | MP0002822_catalepsy | 0.46990975 |
| 72 | MP0008874_decreased_physiological_sensi | 0.46959329 |
| 73 | MP0005164_abnormal_response_to | 0.46248315 |
| 74 | MP0005395_other_phenotype | 0.45829295 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.45258134 |
| 76 | MP0008873_increased_physiological_sensi | 0.45142543 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.45065005 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.44964723 |
| 79 | MP0003718_maternal_effect | 0.44282663 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.43654199 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.43113927 |
| 82 | MP0003724_increased_susceptibility_to | 0.42622735 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.40613558 |
| 84 | MP0003436_decreased_susceptibility_to | 0.40373333 |
| 85 | MP0005248_abnormal_Harderian_gland | 0.39748021 |
| 86 | MP0000579_abnormal_nail_morphology | 0.39670345 |
| 87 | MP0005166_decreased_susceptibility_to | 0.39430323 |
| 88 | MP0003953_abnormal_hormone_level | 0.39098796 |
| 89 | MP0003075_altered_response_to | 0.39017457 |
| 90 | MP0001851_eye_inflammation | 0.38530352 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.38026953 |
| 92 | MP0008872_abnormal_physiological_respon | 0.37901894 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.37765323 |
| 94 | MP0009672_abnormal_birth_weight | 0.35194579 |
| 95 | MP0000467_abnormal_esophagus_morphology | 0.33811331 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.33195767 |
| 97 | MP0002796_impaired_skin_barrier | 0.32639150 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.32119831 |
| 99 | MP0009115_abnormal_fat_cell | 0.31697398 |
| 100 | MP0006082_CNS_inflammation | 0.30381055 |
| 101 | MP0001243_abnormal_dermal_layer | 0.29890387 |
| 102 | MP0001853_heart_inflammation | 0.29824322 |
| 103 | MP0000249_abnormal_blood_vessel | 0.29691988 |
| 104 | MP0002970_abnormal_white_adipose | 0.29206113 |
| 105 | MP0002168_other_aberrant_phenotype | 0.28872775 |
| 106 | MP0001881_abnormal_mammary_gland | 0.28539309 |
| 107 | MP0004883_abnormal_blood_vessel | 0.27486048 |
| 108 | MP0000920_abnormal_myelination | 0.27320298 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.26871382 |
| 110 | MP0005197_abnormal_uvea_morphology | 0.26455617 |
| 111 | MP0002060_abnormal_skin_morphology | 0.25393983 |
| 112 | MP0002090_abnormal_vision | 0.24285821 |
| 113 | MP0002419_abnormal_innate_immunity | 0.24151175 |
| 114 | MP0000427_abnormal_hair_cycle | 0.24088482 |
| 115 | MP0004272_abnormal_basement_membrane | 0.23858449 |
| 116 | MP0002132_abnormal_respiratory_system | 0.23066814 |
| 117 | MP0003959_abnormal_lean_body | 0.22805334 |
| 118 | MP0000858_altered_metastatic_potential | 0.21541171 |
| 119 | MP0002128_abnormal_blood_circulation | 0.21145499 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.20634323 |
| 121 | MP0001545_abnormal_hematopoietic_system | 0.20134384 |
| 122 | MP0005397_hematopoietic_system_phenotyp | 0.20134384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.46474186 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.45198243 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.40274854 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.84130441 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.60900200 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46582025 |
| 7 | Xanthomatosis (HP:0000991) | 6.30522311 |
| 8 | Complement deficiency (HP:0004431) | 5.64803501 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.56531722 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.77469871 |
| 11 | Joint hemorrhage (HP:0005261) | 4.74482083 |
| 12 | Epidermoid cyst (HP:0200040) | 4.67649695 |
| 13 | Hyperammonemia (HP:0001987) | 4.62866764 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45286463 |
| 15 | Hyperglycinemia (HP:0002154) | 4.42956279 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.38797029 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.37323345 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30033271 |
| 19 | Ketosis (HP:0001946) | 4.24365381 |
| 20 | Fat malabsorption (HP:0002630) | 4.22820990 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.19313332 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17102957 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.12466656 |
| 24 | Abnormality of complement system (HP:0005339) | 4.11955257 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.94326733 |
| 26 | Hyperglycinuria (HP:0003108) | 3.87535239 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.87450690 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87450690 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.81213588 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.81206483 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78515406 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.63630836 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38916968 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.33646194 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31367428 |
| 36 | Steatorrhea (HP:0002570) | 3.21768766 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.11386681 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.08625647 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07863106 |
| 40 | Spontaneous abortion (HP:0005268) | 3.01332694 |
| 41 | Ketoacidosis (HP:0001993) | 2.98226886 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.97237762 |
| 43 | Myocardial infarction (HP:0001658) | 2.95913478 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.95848879 |
| 45 | Skin nodule (HP:0200036) | 2.89479100 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.82114768 |
| 47 | Metabolic acidosis (HP:0001942) | 2.72759729 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.64631293 |
| 49 | Lethargy (HP:0001254) | 2.61019376 |
| 50 | Purpura (HP:0000979) | 2.58593776 |
| 51 | Acanthocytosis (HP:0001927) | 2.56724581 |
| 52 | Osteomalacia (HP:0002749) | 2.54912025 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53057272 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52674271 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.52674271 |
| 56 | Spastic diplegia (HP:0001264) | 2.52023670 |
| 57 | Vascular calcification (HP:0004934) | 2.52015120 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.47168122 |
| 59 | Cerebral edema (HP:0002181) | 2.46653663 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.46034426 |
| 61 | Mitral stenosis (HP:0001718) | 2.44142266 |
| 62 | Gout (HP:0001997) | 2.40494527 |
| 63 | Neonatal onset (HP:0003623) | 2.40467943 |
| 64 | Cholelithiasis (HP:0001081) | 2.40421792 |
| 65 | Glomerulonephritis (HP:0000099) | 2.39780864 |
| 66 | Irritability (HP:0000737) | 2.37261702 |
| 67 | Cholecystitis (HP:0001082) | 2.34825188 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.34825188 |
| 69 | Fair hair (HP:0002286) | 2.34266214 |
| 70 | Pulmonary embolism (HP:0002204) | 2.32086668 |
| 71 | Neonatal hypoglycemia (HP:0001998) | 2.25689543 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.23231583 |
| 73 | Amyloidosis (HP:0011034) | 2.21596958 |
| 74 | Malnutrition (HP:0004395) | 2.21279164 |
| 75 | Gingival bleeding (HP:0000225) | 2.18394033 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.17705950 |
| 77 | Esophageal varix (HP:0002040) | 2.15622727 |
| 78 | Brushfield spots (HP:0001088) | 2.14071375 |
| 79 | Pancreatitis (HP:0001733) | 2.11986406 |
| 80 | Late onset (HP:0003584) | 2.09617240 |
| 81 | Enlarged kidneys (HP:0000105) | 2.09424541 |
| 82 | Menorrhagia (HP:0000132) | 2.08892267 |
| 83 | Hyperphosphaturia (HP:0003109) | 2.05577111 |
| 84 | Thrombophlebitis (HP:0004418) | 2.05061585 |
| 85 | Vomiting (HP:0002013) | 2.04411216 |
| 86 | Joint swelling (HP:0001386) | 2.04091260 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.03193228 |
| 88 | Opisthotonus (HP:0002179) | 2.02499983 |
| 89 | Abnormality of the gallbladder (HP:0005264) | 2.01020511 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99556164 |
| 91 | Poikilocytosis (HP:0004447) | 1.98244787 |
| 92 | Generalized aminoaciduria (HP:0002909) | 1.97787771 |
| 93 | Elevated alkaline phosphatase (HP:0003155) | 1.95666127 |
| 94 | Hemorrhage of the eye (HP:0011885) | 1.95558618 |
| 95 | Rickets (HP:0002748) | 1.93360438 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.91007064 |
| 97 | Arthropathy (HP:0003040) | 1.89719877 |
| 98 | Increased mean platelet volume (HP:0011877) | 1.88270765 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 1.88180233 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87494612 |
| 101 | Renal cortical cysts (HP:0000803) | 1.86587443 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 1.85673466 |
| 103 | Glycosuria (HP:0003076) | 1.85673466 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83067744 |
| 105 | Alkalosis (HP:0001948) | 1.82723532 |
| 106 | Elevated hepatic transaminases (HP:0002910) | 1.81909467 |
| 107 | Hypophosphatemic rickets (HP:0004912) | 1.81109018 |
| 108 | Status epilepticus (HP:0002133) | 1.80909860 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.78711724 |
| 110 | Abnormality of proline metabolism (HP:0010907) | 1.78711724 |
| 111 | Hyperglycemia (HP:0003074) | 1.78249282 |
| 112 | Increased serum ferritin (HP:0003281) | 1.77466133 |
| 113 | Abnormality of vitamin metabolism (HP:0100508) | 1.76992118 |
| 114 | Abnormality of the Achilles tendon (HP:0005109) | 1.76933348 |
| 115 | Epistaxis (HP:0000421) | 1.76521318 |
| 116 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76053198 |
| 117 | Bifid scrotum (HP:0000048) | 1.74825214 |
| 118 | Gangrene (HP:0100758) | 1.74112241 |
| 119 | Cerebral palsy (HP:0100021) | 1.73528627 |
| 120 | Nephritis (HP:0000123) | 1.70560915 |
| 121 | Abnormal platelet volume (HP:0011876) | 1.70434713 |
| 122 | Abnormal delivery (HP:0001787) | 1.70318444 |
| 123 | Abnormal platelet function (HP:0011869) | 1.66046703 |
| 124 | Impaired platelet aggregation (HP:0003540) | 1.66046703 |
| 125 | Abnormal urine phosphate concentration (HP:0012599) | 1.63891739 |
| 126 | Generalized hypopigmentation of hair (HP:0011358) | 1.61154138 |
| 127 | Periodontitis (HP:0000704) | 1.54308597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.06340120 |
| 2 | FGFR4 | 4.52681579 |
| 3 | SIK1 | 4.44953712 |
| 4 | ERN1 | 4.35047643 |
| 5 | ERBB4 | 3.24353841 |
| 6 | TAOK3 | 3.17558943 |
| 7 | INSRR | 3.08982150 |
| 8 | PRPF4B | 2.42819444 |
| 9 | MAP2K4 | 2.42364412 |
| 10 | MST1R | 2.10962163 |
| 11 | PKN2 | 2.10424093 |
| 12 | MAPK11 | 1.98427049 |
| 13 | PIK3CG | 1.89386776 |
| 14 | FLT3 | 1.89161683 |
| 15 | LATS1 | 1.72300713 |
| 16 | NTRK3 | 1.68145835 |
| 17 | FER | 1.66931946 |
| 18 | TYK2 | 1.65661588 |
| 19 | TRIB3 | 1.60369126 |
| 20 | MAP3K12 | 1.57237321 |
| 21 | ABL2 | 1.53229286 |
| 22 | NLK | 1.53143210 |
| 23 | DAPK2 | 1.52475290 |
| 24 | FRK | 1.49572191 |
| 25 | FGFR2 | 1.49106837 |
| 26 | PTK6 | 1.44058049 |
| 27 | NEK9 | 1.43528840 |
| 28 | MAP3K2 | 1.39732655 |
| 29 | MYLK | 1.39106270 |
| 30 | BLK | 1.38909142 |
| 31 | CAMKK2 | 1.28388522 |
| 32 | MAP3K7 | 1.27041061 |
| 33 | JAK2 | 1.25478384 |
| 34 | KDR | 1.24250527 |
| 35 | PINK1 | 1.13999767 |
| 36 | PRKAA2 | 1.13313476 |
| 37 | ERBB2 | 1.11133609 |
| 38 | MAP3K14 | 1.08800719 |
| 39 | ZAP70 | 1.06105143 |
| 40 | MAP3K10 | 1.05189506 |
| 41 | GRK6 | 1.04411587 |
| 42 | TBK1 | 1.04280392 |
| 43 | JAK1 | 1.03939687 |
| 44 | MAP2K3 | 1.01970530 |
| 45 | MAPK4 | 1.00550476 |
| 46 | KSR2 | 0.95854933 |
| 47 | SCYL2 | 0.94343903 |
| 48 | PRKCZ | 0.93972340 |
| 49 | MAPK15 | 0.93120981 |
| 50 | STK38L | 0.86941945 |
| 51 | MET | 0.85160692 |
| 52 | EPHB1 | 0.82800471 |
| 53 | MAPK12 | 0.82249543 |
| 54 | CDK6 | 0.81333926 |
| 55 | MAP3K3 | 0.79895324 |
| 56 | PDGFRA | 0.78600241 |
| 57 | EPHA3 | 0.78072025 |
| 58 | CAMK2G | 0.77533227 |
| 59 | PRKACG | 0.75952872 |
| 60 | TNK2 | 0.75559282 |
| 61 | TIE1 | 0.73923993 |
| 62 | MAP3K11 | 0.69094999 |
| 63 | CSK | 0.68457469 |
| 64 | MAP2K6 | 0.67015833 |
| 65 | SGK3 | 0.66697975 |
| 66 | CAMK1D | 0.66470058 |
| 67 | GSK3A | 0.65615212 |
| 68 | PRKAA1 | 0.65484223 |
| 69 | IRAK3 | 0.65472758 |
| 70 | DYRK1B | 0.65189740 |
| 71 | PRKG1 | 0.63531235 |
| 72 | MAPK7 | 0.62653710 |
| 73 | FGFR3 | 0.61045387 |
| 74 | RIPK1 | 0.59332056 |
| 75 | CSF1R | 0.57432220 |
| 76 | PRKACA | 0.57283372 |
| 77 | JAK3 | 0.56751733 |
| 78 | IKBKE | 0.54332306 |
| 79 | KIT | 0.53914647 |
| 80 | TGFBR2 | 0.53634636 |
| 81 | PRKCQ | 0.53032918 |
| 82 | PKN1 | 0.52623020 |
| 83 | EPHA4 | 0.52584781 |
| 84 | PDPK1 | 0.52539425 |
| 85 | PTK2 | 0.51529496 |
| 86 | CSNK1G1 | 0.51368526 |
| 87 | SGK2 | 0.50102317 |
| 88 | MAP3K13 | 0.47747748 |
| 89 | MAP3K5 | 0.45863251 |
| 90 | SRC | 0.44537920 |
| 91 | GRK1 | 0.44211511 |
| 92 | RET | 0.42429794 |
| 93 | MAP2K1 | 0.42355315 |
| 94 | ACVR1B | 0.42088504 |
| 95 | TAOK2 | 0.41871670 |
| 96 | PRKCB | 0.41177841 |
| 97 | PRKCG | 0.40966367 |
| 98 | CDK4 | 0.38740482 |
| 99 | ICK | 0.38158184 |
| 100 | MAP3K6 | 0.36935813 |
| 101 | PDK2 | 0.36693564 |
| 102 | EGFR | 0.36367506 |
| 103 | SGK223 | 0.34157891 |
| 104 | SGK494 | 0.34157891 |
| 105 | MTOR | 0.34140867 |
| 106 | CSNK1D | 0.33919864 |
| 107 | PBK | 0.32821518 |
| 108 | RPS6KA3 | 0.32748073 |
| 109 | PIK3CA | 0.32330585 |
| 110 | PDK1 | 0.32302480 |
| 111 | PRKACB | 0.32009260 |
| 112 | CSNK1G2 | 0.31960930 |
| 113 | CAMKK1 | 0.31304044 |
| 114 | CAMK4 | 0.31228837 |
| 115 | IRAK2 | 0.29706812 |
| 116 | LATS2 | 0.29261390 |
| 117 | IRAK1 | 0.29012877 |
| 118 | EIF2AK1 | 0.28067220 |
| 119 | CDC42BPA | 0.27847256 |
| 120 | CSNK1G3 | 0.27572091 |
| 121 | ARAF | 0.27286815 |
| 122 | PRKCA | 0.26746376 |
| 123 | MAP3K1 | 0.24419304 |
| 124 | ABL1 | 0.23948890 |
| 125 | * IGF1R | 0.22691178 |
| 126 | PAK3 | 0.22536536 |
| 127 | CAMK1G | 0.22252996 |
| 128 | PDK4 | 0.20949938 |
| 129 | PDK3 | 0.20949938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.65403596 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61745166 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46469463 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33486518 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11886120 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77333048 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63984433 |
| 8 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61237500 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58274280 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55170623 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47398612 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37070529 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23925437 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15755075 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12763433 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09386038 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96440158 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96022695 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94243573 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90608301 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90164995 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89569662 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85699016 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77595012 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76534874 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76332890 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73444699 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73249663 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70326962 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67306995 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58443421 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57754294 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52643599 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50602018 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50146720 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48560019 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45614339 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34953747 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33908135 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32392544 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30107673 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28649951 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21308725 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.20471894 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20285447 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15947281 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12972781 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10907051 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06772763 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00413844 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99180800 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95047528 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94353913 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92500959 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92091585 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87881371 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81864566 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81493384 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80976865 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73905243 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68394476 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65535950 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65492731 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54606489 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52037219 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46174893 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44803380 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.43114060 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.42470624 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41589010 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23556900 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23252234 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.22596748 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21967036 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21680721 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21453176 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17556486 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15333425 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10293914 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05380012 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01563698 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2646614 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2546804 |
| 84 | Lysosome_Homo sapiens_hsa04142 | -0.2532282 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2508007 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2394459 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2375644 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2353591 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2350090 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2242619 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | -0.2159356 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2115903 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1979845 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1954397 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1938064 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1795645 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1772923 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1720968 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1677509 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1521673 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1518335 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1302351 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1231432 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1047334 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0985376 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0825448 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0624440 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0562488 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | -0.0356217 |
| 110 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0239127 |

